Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention

Bianca Rocca, Jaqui Walker, Marco Cattaneo, Lina Badimon, Giancarlo Agnelli, Andrew T. Chan, Angel Lanas, Peter Rothwell, Paola Patrignani, Ruth Langley, Gemma Vilahur, Francesco Cosentino

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

Abstract

At the 2019 International Aspirin Foundation Scientific Conference 'Benefits and Risks of Antithrombotic Therapy for Cardiovascular Disease Prevention', held in Rome, Italy, international experts sought to discuss and debate the optimal antithrombotic strategy for the secondary prevention of cardiovascular disease (CVD) and to seek agreement around dosing and target populations for aspirin use in primary disease prevention. Getting the best evidence to support real-life decisions in the clinic can be complex, and individualising management in order to balance both the risks and benefits of different disease prevention strategies appears to be the best approach. It is hoped that future decision-making tools and biomarkers will help direct treatments at those most likely to benefit.
Lingua originaleEnglish
pagine (da-a)1-13
Numero di pagine13
Rivistaecancermedicalscience
Volume2020
DOI
Stato di pubblicazionePubblicato - 2020

Keywords

  • anticoagulant
  • antiplatelet
  • antithrombotic
  • aspirin
  • benefit
  • cardiovascular disease (CVD)
  • colorectal cancer (CRC)
  • diabetes mellitus (DM)
  • gastroprotectant agents
  • optimizing aspirin dose
  • precision medicine
  • primary prevention
  • risk
  • secondary prevention
  • targeting
  • upper gastrointestinal (GI) bleeding

Fingerprint

Entra nei temi di ricerca di 'Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention'. Insieme formano una fingerprint unica.

Cita questo